Allergan chief snaps up a rival biotech for $195M in cash, plus. Deal beefs up the aesthetics pipeline
Just after the start of the year, the crew of ex-Allergan execs that launched Bonti raised more than $15 million to back their development of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
